Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,463 recalls · Class I, newest first

Class I · High risk

Lite Fit USA

Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, lot 13165, due to undeclared sibutramine, making it an unapproved new drug.

Terminated Chemical / undeclared Bacai Inc. Dba Ky Duyen House D-1534-2014
Class I · High risk

Marcaine (bupivacaine HCl)

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-1559-10 D-1358-2014
Class I · High risk

1% LIDOCAINE HCl Injection

Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4279-02 D-0382-2015
Class I · High risk

Super ARTHGOLD 500mg

Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and chlorzoxazone.

Terminated Chemical / undeclared Sung Soo Kim D-1535-2014
Class I · High risk

Thinogenics

Marketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine.

Terminated Chemical / undeclared Nature's Universe D-1594-2014
Class I · High risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1547-2014
Class I · High risk

Mojo Risen

Marketed Without an Approved NDA/ANDA; Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.

Terminated Chemical / undeclared Nova Products, Inc. D-1603-2014
Class I · High risk

Xzone Gold

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZONE GOLD because FDA laboratory analysis determined that they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to treat erectile dysfunction.

Terminated Chemical / undeclared Nova Products, Inc. D-1602-2014
Class I · High risk

Xzone 1200

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZone 1200because FDA laboratory analysis determined that they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to treat erectile dysfunction.

Terminated Chemical / undeclared Nova Products, Inc. D-1601-2014
Class I · High risk

Xzen 1200

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Xzen 1200 because FDA laboratory analysis determined they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to treat erectile dysfunction.

Terminated Chemical / undeclared Nova Products, Inc. D-1600-2014
Class I · High risk

Xzen Platinum

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZEN PLATINUM because FDA laboratory analysis determined they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to treat erectile dysfunction.

Terminated Chemical / undeclared Nova Products, Inc. D-1599-2014
Class I · High risk

Xzen Gold

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZEN GOLD because FDA laboratory analysis determined they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to treat erectile dysfunction.

Terminated Chemical / undeclared Nova Products, Inc. D-1598-2014
Class I · High risk

Black Ant

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Black Ant because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.

Terminated Chemical / undeclared Nova Products, Inc. D-1597-2014
Class I · High risk

African Black Ant

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.

Terminated Chemical / undeclared Nova Products, Inc. D-1596-2014
Class I · High risk

Esmeralda

Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed as Dietary Supplements due to the presence of undeclared and unapproved drugs.

Terminated Chemical / undeclared New Life Nutritional Center D-0317-2015
Class I · High risk

Maxi Gold Weight Loss Pill

Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed as Dietary Supplements due to the presence of undeclared and unapproved drugs.

Terminated Chemical / undeclared New Life Nutritional Center D-0316-2015
Class I · High risk

New Life Nutritional SUPER FAT BURNER

Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed as Dietary Supplements due to the presence of undeclared and unapproved drugs.

Terminated Chemical / undeclared New Life Nutritional Center D-0315-2015
Class I · High risk

REUMOFAN PLUS Tablets

Marketed Without an Approved NDA/ANDA; Product contains undeclared diclofenac and methocarbamol.

Terminated Chemical / undeclared Pain Free By Nature D-1322-2014
Class I · High risk

Venlafaxine HCl Extended-Release Capsules

Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot

Terminated Particulate / foreign matter Greenstone Llc NDC 59762-0182-2 D-1361-2014

Recalls by year